Crinetics Pharmaceuticals (CRNX) Stock Chart & Stock Price History → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free CRNX Stock Alerts $42.29 -1.03 (-2.38%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Crinetics Pharmaceuticals Stock Price Performance5 Day Performance-1.49%1 Month Performance-1.83%3 Month Performance+13.64%6 Month Performance+48.74%Year-To-Date Performance+18.97%1 Year Performance+127.95% Receive CRNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. CRNX Stock Chart for Thursday, April, 25, 2024 CRNX Chart by TradingView Crinetics Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$44.22$43.32-2.04%$45.26$43.28421,077 shs$3.02 billion04/23/2024$43.44$44.22+1.80%$44.78$42.05612,425 shs$3.08 billion04/22/2024$42.97$43.44+1.09%$43.76$42.71465,271 shs$3.02 billion04/19/2024$43.01$42.97-0.09%$44.21$42.20624,655 shs$2.99 billion04/18/2024$44.01$43.01-2.27%$44.54$42.87538,897 shs$2.99 billion04/17/2024$43.49$44.01+1.20%$44.31$43.28507,335 shs$3.06 billion Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$43.68$43.49-0.43%$44.29$42.63472,414 shs$3.03 billion04/15/2024$44.59$43.68-2.04%$44.88$43.44540,666 shs$3.04 billion04/12/2024$48.03$44.59-7.16%$48.23$43.711.11 million shs$3.10 billion04/11/2024$45.90$48.03+4.64%$48.53$46.20684,737 shs$3.34 billion04/10/2024$46.91$45.90-2.15%$46.50$45.17534,956 shs$3.19 billion04/09/2024$46.44$46.91+1.01%$47.23$46.09668,499 shs$3.26 billion04/08/2024$47.53$46.44-2.29%$48.31$45.75550,241 shs$3.23 billion04/05/2024$46.65$47.53+1.89%$48.63$45.52668,211 shs$3.31 billion04/04/2024$47.62$46.65-2.04%$49.58$46.001.23 million shs$3.25 billion04/03/2024$46.00$47.62+3.52%$48.13$44.912.91 million shs$3.31 billion04/02/2024$46.53$46.00-1.14%$46.07$44.43858,683 shs$3.20 billion04/01/2024$46.81$46.53-0.60%$47.62$44.521.09 million shs$3.24 billion03/29/2024$46.81$46.81$47.16$44.011.29 million shs$3.26 billion03/28/2024$44.43$46.81+5.36%$47.16$44.011.29 million shs$3.26 billion03/27/2024$43.37$44.43+2.44%$44.64$43.10836,861 shs$3.09 billion03/26/2024$43.12$43.37+0.58%$44.28$42.68618,794 shs$3.02 billion03/25/2024$44.29$43.12-2.64%$44.52$42.33651,584 shs$3.00 billion03/22/2024$44.97$44.29-1.51%$45.00$43.72599,537 shs$3.08 billion03/21/2024$45.49$44.97-1.14%$46.00$44.65860,836 shs$3.13 billion03/20/2024$45.18$45.49+0.69%$46.76$42.701.67 million shs$3.17 billion03/19/2024$37.93$45.18+19.11%$45.98$40.983.09 million shs$3.14 billion03/18/2024$38.93$37.93-2.57%$39.06$37.52773,547 shs$2.64 billion03/15/2024$38.21$38.93+1.88%$39.38$37.961.73 million shs$2.71 billion03/14/2024$40.50$38.21-5.65%$40.36$37.45791,400 shs$2.66 billion03/13/2024$40.75$40.50-0.61%$41.92$39.96643,152 shs$2.82 billion03/12/2024$41.57$40.75-1.97%$41.76$40.45525,974 shs$2.84 billion03/11/2024$42.29$41.57-1.70%$42.50$41.40514,471 shs$2.89 billion03/08/2024$42.50$42.29-0.49%$44.33$41.59396,183 shs$2.94 billion03/07/2024$43.52$42.50-2.34%$43.59$42.32524,918 shs$2.96 billion03/06/2024$42.93$43.52+1.37%$45.14$43.05429,690 shs$3.03 billion03/05/2024$43.51$42.93-1.33%$44.07$42.40663,589 shs$2.99 billion03/04/2024$46.03$43.51-5.47%$47.58$42.93667,961 shs$3.03 billion03/01/2024$40.94$46.03+12.43%$47.01$41.221.12 million shs$3.07 billion02/29/2024$42.76$40.94-4.26%$45.94$40.581.35 million shs$2.73 billionWorld’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do.02/28/2024$40.47$42.76+5.66%$47.34$42.381.86 million shs$2.86 billion02/27/2024$38.67$40.47+4.65%$40.79$38.50731,800 shs$2.70 billion02/26/2024$36.85$38.67+4.94%$38.70$36.75418,462 shs$2.58 billion02/23/2024$36.72$36.85+0.35%$37.60$36.48349,054 shs$2.46 billion02/22/2024$36.40$36.72+0.88%$37.43$36.10473,746 shs$2.45 billion02/21/2024$37.42$36.40-2.73%$37.72$36.11385,249 shs$2.43 billion02/20/2024$37.82$37.42-1.06%$38.31$36.81457,807 shs$2.50 billion02/19/2024$37.82$37.82$37.90$36.58489,100 shs$2.53 billion02/16/2024$36.92$37.82+2.44%$37.90$36.73488,952 shs$2.53 billion02/15/2024$36.31$36.92+1.68%$37.25$35.86575,874 shs$2.47 billion02/14/2024$35.99$36.31+0.89%$36.76$35.79560,835 shs$2.43 billion02/13/2024$39.30$35.99-8.42%$38.14$35.821.31 million shs$2.40 billion02/12/2024$39.46$39.30-0.41%$40.50$39.12650,678 shs$2.63 billion02/09/2024$38.46$39.46+2.61%$39.49$38.33514,741 shs$2.64 billion02/08/2024$37.78$38.46+1.79%$39.19$37.38821,330 shs$2.57 billion02/07/2024$37.82$37.78-0.11%$38.09$37.11550,514 shs$2.52 billion02/06/2024$37.67$37.82+0.40%$38.97$37.251.28 million shs$2.53 billion02/05/2024$37.08$37.67+1.59%$37.69$36.09400,599 shs$2.52 billion02/02/2024$37.21$37.08-0.35%$37.27$35.72513,768 shs$2.48 billion02/01/2024$36.48$37.21+2.00%$37.87$36.30717,671 shs$2.49 billion01/31/2024$37.04$36.48-1.51%$37.57$36.19451,107 shs$2.44 billion01/30/2024$37.70$37.04-1.75%$37.49$36.11529,106 shs$2.47 billion01/29/2024$37.18$37.70+1.40%$37.76$36.62709,697 shs$2.52 billion01/26/2024$37.25$37.18-0.19%$38.04$36.52768,428 shs$2.48 billion01/25/2024$36.91$37.25+0.92%$38.19$36.83626,495 shs$2.49 billion01/24/2024$37.61$36.91-1.86%$38.00$36.31810,560 shs$2.47 billion Related Companies: Xenon Pharmaceuticals Stock Chart Bausch Health Companies Stock Chart Amicus Therapeutics Stock Chart HUTCHMED Stock Chart Arrowhead Pharmaceuticals Stock Chart Biohaven Stock Chart IDEAYA Biosciences Stock Chart MoonLake Immunotherapeutics Stock Chart ACADIA Pharmaceuticals Stock Chart MorphoSys Stock Chart Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRNX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.